Literature DB >> 17656910

Long term topical application of lactic acid/lactate lotion as a preventive treatment for acne vulgaris.

Taru Garg1, M Ramam, J S Pasricha, K K Verma.   

Abstract

In an open clinical study, efficacy of 5% aqueous solution of lactate for preventing acne was evaluated in 22 patients. Lactate lotion was used topically all over the face twice a day and continued like a cosmetic for 1 year. Systematic antibiotics were given for periods of 4 weeks whenever the disease was severe. The effect of the treatment was evaluated by counting the number of comedones, inflammatory lesions and cysts separately once a month and recording them graphically. The greatest reduction in the lesion counts was achieved in 8-24 weeks for the inflammatory lesions and 8-30 weeks for the comedones. At the end of 1 year 90-100% reduction of the inflammatory lesions was achieved in 40.9% patients and non-inflammatory lesions in 22.7% patients. The remaining patients showed 50-90% reduction, while 2 patients showed less than 50% reduction in the non-inflammatory lesions. Thus, most of the patients showed significant reduction in the lesion counts. Aggravations were associated with the hot and the rainy season and required concomitant treatment with oral antibiotics.

Entities:  

Year:  2002        PMID: 17656910

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  4 in total

1.  [Acne vulgaris. Role of cosmetics].

Authors:  H C Korting; C Borelli; C Schöllmann
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

2.  Acne vulgaris treatment : the current scenario.

Authors:  Sanjay K Rathi
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

3.  Efficacy of 2% metronidazole gel in moderate acne vulgaris.

Authors:  Effat Khodaeiani; Rohollah F Fouladi; Neda Yousefi; Mehdi Amirnia; Shahla Babaeinejad; Javad Shokri
Journal:  Indian J Dermatol       Date:  2012-07       Impact factor: 1.494

Review 4.  Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.

Authors:  Ross Cromarty; Derseree Archary
Journal:  AIDS Res Treat       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.